News
Has the Tide Turned for Carnival Corp.?
Travel company Carnival Corp. (NYSE: CCL), best known for its portfolio of cruise ship lines, has struggled since the early days of the COVID-19 pandemic, when it fought for financial survival.
As
Got $500? These Hot Growth Stocks Are Screaming Buys Right Now
They're often grouped together, but not all growth stocks are the same. Indeed, they're each dramatically different in terms of risk, potential, and longevity. One's not inherently as good as
Is It Too Late to Buy Realty Income Stock?
Shares of Realty Income (NYSE: O) trade down around 33% from their pre-pandemic highs in early 2020. But nothing material has changed about the business, or at least not in a permanently negative
How Much Money Does Warren Buffett Have Invested in Occidental Petroleum?
Warren Buffett isn't shy about making big bets. Within Berkshire Hathaway's portfolio of publicly traded stocks, just 10 positions comprise more than 90% of its invested capital.
One of those
5 Reasons to Love Meta Platforms Stock
When Wall Street is too focused on the short term it can create great buying opportunities for patient investors. You can scoop up shares in a stock during periods of elevated pessimism and set
Carvana's Debt Problems Haven't Gone Away. Investors Should Keep a Close Eye On These 3 Things
On the surface, Carvana (NYSE: CVNA) looks like it had a spectacular turnaround year in 2023. Earnings rocketed from a $15.74 per share loss in 2022 to a profit of $4.12 per share. And it also seems
1 Wall Street Analyst Thinks Alphabet Stock Is Going to $200. Is It a Buy?
Alphabet (NASDAQ: GOOG) (NASDAQ: GOOGL) has been on a tear lately as far as its stock is concerned. That's because it has many factors going for it, including good fundamentals, investor hunger for
Better Quantum Computing Stock: IBM vs. IonQ
IBM (NYSE: IBM) and IonQ (NYSE: IONQ) are both investing in the long-term growth of the quantum computing market. While traditional computers process data as binary "bits" of zeros and ones, quantum
Peloton Stock Has 90% Upside, According to 1 Wall Street Analyst
Peloton Interactive (NASDAQ: PTON) investors had a crazy week. The stock slipped 22% on Thursday after Peloton reported its CEO is stepping down and it missed on Q3 2024 sales, while reporting
Is Boeing Stock a Buy?
Despite all its issues over the last few years, there's still a robust case for buying Boeing (NYSE: BA) stock. After all, it's still one of only two truly global players in the commercial airplane
3 Super-Safe Dividend Stocks That Have Been Making Recurring Payments for 130+ Years
A company's track record for paying dividends is a good indicator of how versatile and adaptable the business is in dealing with changing economic conditions. That doesn't mean that the dividend
Is Caterpillar Stock a Buy?
Caterpillar (NYSE: CAT) stock dropped 9% since its most recent earnings report as the world's largest construction equipment manufacturer faces a dwindling backlog amid higher interest rates
Where Will Lucid Stock Be in 3 Years?
Lucid (NASDAQ: LCID) went public by merging with a special purpose acquisition company (SPAC) nearly three years ago. The luxury electric vehicle maker initially gained a lot of attention because it
Should You Buy ChargePoint While More Money Is Going Out Than Coming In?
ChargePoint (NYSE: CHPT) does something very important: It installs and provides services for electric vehicle (EV) charging sites. These are necessities if the world is going to shift from
Where Will Arm Holdings Stock Be in Five Years?
With shares up by a whopping 37% year to date, Arm Holdings (NASDAQ: ARM) is one of many technology companies that have received significant attention because of their potential in artificial
2 Stocks to Buy With $1,000
Looking to invest $1,000? Right now, I say go for tried and true companies. To that end, I've selected two stocks that I think have demonstrated track records of delivering for shareholders. I like
2 Magnificent Dividend Stocks to Hold for the Next Decade
There are many reasons to invest in excellent dividend stocks. Such investments are often worth the trouble regardless of whether you're investing for the dividend, or for making capital gains from
Warren Buffett Bought $9.2 Billion of This Stock Last Year, and He Could Buy Even More in 2024
There are a lot of good reasons to pay attention to every investment decision Warren Buffett makes.
Besides being the chairman and CEO of the eighth largest public company in the world, Buffett has
3 Magnificent Technology ETFs to Buy With $10,000 and Hold Forever
Investing in the stock market can be hard. After all, there are tens of thousands of investment options to choose from. So, where's the best place to start?
In my opinion, exchange-traded funds
Is Tesla Stock Going to $230? 1 Wall Street Analyst Thinks So.
Even after a sharp recovery in recent weeks, Tesla (NASDAQ: TSLA) stock has had a rough run this year. But one analyst thinks the odds are good that the latest move higher can continue. Cantor
This Is Great News for Medical Properties Trust and Its 16%-Yielding Dividend
Medical Properties Trust (NYSE: MPW) has been a polarizing stock to own and watch in recent years. It has an incredibly high-dividend yield of 16%, which can be enticing to investors seeking a high
This Dividend King Thinks 2024 Will Be Better Than Expected. Is It a Buy?
Over the past five decades, S&P Global (NYSE: SPGI) has steadily raised its dividend payout, proving to be a reliable dividend stock you can count on. The company enjoys a robust business model and
Should You Buy This Popular Video Game Stock Before May 16?
Take-Two Interactive (NASDAQ: TTWO) has some big questions to answer for investors in a few weeks. The video game developer's stock soared through late 2023, but it has trailed the market recently
Apple Has a Problem -- and Investors Should Love It
It's tougher than you might think to be a $2.8 trillion company. Apple (NASDAQ: AAPL) faces a more challenging task to continue the success of its past the bigger it gets.
The tech giant announced
3 Reasons to Buy AbbVie Stock on the Dip
It's been more than a year since AbbVie (NYSE: ABBV) lost patent exclusivity for its most important product, Humira, an immunology medicine. Though this was a long time coming, the market reacted as